Estimates Revisions Unicycive Therapeutics, Inc.
Stocks
UNCY
US90466Y2028
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 12/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 5.390 USD | +7.80% |
|
+3.06% | -6.59% |
| 08-12 | Unicycive Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Top Midday Decliners | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- UNCY Stock
- Consensus Unicycive Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
